Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours Β· Estimated delivery Aug 8 - Aug 13
In these trials, MOUNJARO (5 mg, 10 mg, and 15 mg given subcutaneously once weekly) was compared with placebo, semaglutide 1 mg, insulin degludec, and/or insulin glargine [see Clinical Studies (14.2, 14.3, 14.4)]
Who Should Use This Product: This product is intended for adults seeking targeted support for joint health, digestive function, and gut-brain axis balance, particularly when lower gastrointestinal support is desired
The beta-3 adrenergic pathway that AOD 9604 activates is highly expressed in visceral adipose tissue, making it a targeted tool for belly fat reduction
The mean duration of type 2 diabetes mellitus was 2.4 years, mean HbA1c was 8.0%, mean weight was 97 kg, and the mean baseline BMI was 35 kg/m2
Some compounding pharmacies and research sources list it as AOD-9604, AOD9604, or HGH Frag 176-191
Start: Begin around 300 mcg per day to gauge tolerability, then adjust as needed
US$ 20.53
US$ 25.28
US$ 24.43
US$ 22.27
US$ 27.92
US$ 27.14
